Epirium Domain Overview🔒 SSL Verified
Live Data Status: |E-commerce & Retail
Welcome to the detailed analysis for epirium.com. This domain is officially recognized as Epirium Bio. According to their official web presence, their primary focus is: "Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.".
Table of Contents
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 20Outbound Links: 4
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$1,091
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- epirium.comAvailable
- epirium.netAvailable
- epirium.orgTaken
- epirium.ioTaken
- epirium.coTaken
- epirium.aiTaken
Official Contact & Profiles
Emails: [email protected], [email protected]
Content Snippets from epirium.com
"Epirium Bio is a biopharmaceutical company that has identified and established an IP-protected platform of orally bioavailable small molecules that leverages the potential of PGE-2 signaling to restore tissue homeostasis, resolving aberrant inflammation, stimulating regeneration, and reducing fibrosis. Our oral therapies have the potential to improve function in neuromuscular diseases including sarcopenia, inflammatory and fibrotic diseases."
"Our lead small molecule, MF-300 is currently in a Phase 2b study in sarcopenia, and we have generated preclinical efficacy data across a broad scope of indications with significant unmet medical need, including spinal muscular atrophy (SMA), irritable bowel disease (IBD), and idiopathic pulmonary fibrosis (IPF)."
"The company was founded in 2008 in San Diego, Calif., by Pam Taub, M.D., FACC; Alan Maisel, M.D.; Francisco Villarreal, M.D., Ph.D.; and Jonathan Taub, who also served as the first chief executive officer (CEO). It was founded based on initial observations that (-)-epicatechin protected against animal models of cardiac ischemia and heart failure, with a mechanism of action that appeared to be mediated via trophic effects on mitochondria function and density. Subsequent insights from the efforts of Guillermo Ceballos, M.D., recognized as another founding scientist, also helped guide the company to focus on muscle diseases."
"In 2009, the company became Cardero Therapeutics, Inc. with George Schreiner, M.D., Ph.D., joining as CEO, and Sundeep Dugar, Ph.D., serving as consulting head of medicinal chemistry. Dr. Dugar joined the company fulltime as chief technology officer (CTO) in 2012."
Key Topics & Focus Areas for epirium.com:
Our History
Patient Resources
For Clinical Study Inquiries, please contact [email protected]
For additional information, please contact [email protected]
By comparing epirium.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to epirium.com.
Frequently Asked Questions
Is epirium.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of epirium.com?
As of July 24, 2026, epirium.com holds an estimated domain authority score of 53/100 based on our VisitRank tracking algorithms.
What are the top alternatives to epirium.com?
You can find the best alternatives and similar sites to epirium.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for epirium.com:
eiprium.comeprium.comeppirium.comapirium.comeporium.comepiroum.comepiriom.comeoirium.comelirium.com